Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Essentials - Sleep Problems Complicated by Substance Use Disorders

    Contains 4 Component(s), Includes Credits

    This lecture will provide an overview of normal sleep followed by a detailed description of how SUDs impact it. Clinicians can use the information to educate and motivate their patients as part of the recovery plan. Nonpharmacologic suggestions will help clinicians provide evidenced based solutions.

    This lecture will provide an overview of normal sleep followed by a detailed description of how SUDs impact it. Clinicians can use the information to educate and motivate their patients as part of the recovery plan.
    Nonpharmacologic suggestions will help clinicians provide evidenced based solutions.

    Substance Use Disorders are one of the major medical disorders whether measured in personal, economic, or epidemiologic terms. All physicians will encounter patients with substance use disorders and primary care providers are the gateway to both initial treatment and subsequent referrals to specialists. This CME will provide participants with the knowledge, skills, and abilities to discuss substance use disorders with their patients in terms of how SUDs impact sleep and offer suggestions as part of a treatment plan that addresses sleep problems.

    Learning Objectives:
    1.Learn the basic elements of the sleep cycle.
    2.Learn how SUDs impact sleep and ways to improve the patients quality of life and recovery.


    R. Gregory Lande, DO, FAOAAM (Moderator)

    R. Gregory Lande, DO is a past president of the AOAAM.

    Dr. Lande retired from active duty military service and now practices psychiatry at Walter Reed National Military
    Medical center in Bethesda, MD.
    He is the author of over 100 articles, chapters, and books.

  • Essentials - Motivational Interviewing

    Contains 4 Component(s), Includes Credits

    Motivational Interviewing is a psychotherapy which helps individuals understand and manage their reluctance to change behavior. Overcoming this resistance is a fundamental step in helping individuals with a substance use disorder begin the process of recovery.

    Motivational Interviewing is a psychotherapy which helps individuals understand and manage their reluctance to change behavior. Overcoming this resistance is a fundamental step in helping individuals with a substance use disorder begin the process of recovery.

    Substance Use Disorders are one of the major medical disorders whether measured in personal, economic, or epidemiologic terms. All physicians will encounter patients with substance use disorders and primary care providers are the gateway to both initial treatment and subsequent referrals to specialists. This CME will provide participants with the knowledge, skills, and abilities to discuss substance use disorders with their patients and make informed treatment plans and referrals.

    Learning Objectives:
    1. Learn the basic elements of Motivational Interviewing.
    2. Engage the topic through video examples which will reinforce key concepts.


    R. Gregory Lande, DO, FAOAAM

    R. Gregory Lande, DO is a past president of the AOAAM.

    Dr. Lande retired from active duty military service and now practices psychiatry at Walter Reed National Military
    Medical center in Bethesda, MD.
    He is the author of over 100 articles, chapters, and books.

  • Essentials - Assessment of Patients with Substance Use Disorders

    Contains 4 Component(s), Includes Credits

    This course will focus on the screening, brief intervention and referral to treatment of the patients.

    There is strong evidence of the value and efficacy for universal screening for substance use problems in health care settings. The tenants of this model of care will be presented. There will be attention paid to integrating SBIRT into the primary care setting.

    Learning Objectives:

    1. The importance of universal screening for substance use disorders.
    2. The current validated models of SBIRT
    3. The foundation of engaging a patient in a brief intervention.


    R. Gregory Lande, DO, FAOAAM

    R. Gregory Lande, DO is a past president of the AOAAM.

    Dr. Lande retired from active duty military service and now practices psychiatry at Walter Reed National Military
    Medical center in Bethesda, MD.
    He is the author of over 100 articles, chapters, and books.

  • Essentials - Adolescent Substance Use- How to Recognize Screen and Communicate

    Contains 4 Component(s), Includes Credits

    Epidemiology & prevalence of drug use in young adults and teens and will include clinical pathways available for clinicians.

    Epidemiology and prevalence of drug use in young adults and teens and will include clinical pathways available for clinicians.

    Learning Objectives:
    1. Understand what drugs are used
    2. Accept data that outline frequency of use
    3. Options available to parents and teens for treatment

    Marla Kushner, DO, FACOFP, FASAM, FSAHM

    Dr. Marla Kushner graduated from the Michigan State University College of Osteopathic Medicine. She completed her Family Medicine residency at Botsford General Hospital in Farmington Hills, Michigan and completed an Adolescent/ Young Adult Medicine Fellowship at Chicago Osteopathic Hospital and Rush-Pres St. Lukes Hospital in Chicago. After her fellowship Dr. Kushner began working with adolescent substance abuse facilities in Chicago and received certification in Addiction Medicine from the American Society of Addiction Medicine and is a distinguished fellow of ASAM. She is a Diplomate in the American Board of Addiction Medicine.  Dr. Kushner received her fellowship in the American College of Osteopathic Family Physicians in March 2013 and is currently the medical director for New Hope Recovery Center in Chicago and two high school-based health centers in Chicago. She has a family medicine practice with a focus on adolescent and addiction medicine.

  • Essentials - Acute Post-Operative Pregnancy Pain with At-Risk Women

    Contains 4 Component(s), Includes Credits

    Attendees will gather an understanding of the ways to screen for Substance Use disorder in at-risk women and provide different ways to manage postpartum and post-operative pain.

    Attendees will gather an understanding of the ways to screen for Substance Use disorder in at-risk women and provide different ways to manage post-partum and post-operative pain.

     Learning Objectives:

    1. The attendee will learn Osteopathic Manipulative Medicine options to treat pregnant and post op women for pain.

    2. The attendee will learn how to assess for the risk of potential substance abuse in a pregnant or postoperative woman.

    3. The attendee will have an understanding of postpartum and pregnancy management that focuses on non-narcotic pain management when appropriate. 

    Marla Kushner, DO, FACOFP, FASAM, FSAHM

    Dr. Marla Kushner graduated from the Michigan State University College of Osteopathic Medicine. She completed her Family Medicine residency at Botsford General Hospital in Farmington Hills, Michigan and completed an Adolescent/ Young Adult Medicine Fellowship at Chicago Osteopathic Hospital and Rush-Pres St. Lukes Hospital in Chicago. After her fellowship Dr. Kushner began working with adolescent substance abuse facilities in Chicago and received certification in Addiction Medicine from the American Society of Addiction Medicine and is a distinguished fellow of ASAM. She is a Diplomate in the American Board of Addiction Medicine.  Dr. Kushner received her fellowship in the American College of Osteopathic Family Physicians in March 2013 and is currently the medical director for New Hope Recovery Center in Chicago and two high school-based health centers in Chicago. She has a family medicine practice with a focus on adolescent and addiction medicine.

  • Essentials - Assessment and Management of Tobacco Use Disorders

    Contains 4 Component(s), Includes Credits

    The World Health Organization has identified nicotine dependence as the number one preventable illness leading to the highest morbidity and mortality rates in the world. This presentation will review the epidemiology, the co-morbidity with behavioral health problem, and common screening and brief interventions in addressing the troubling problem with the patient. There will be a review of the FDA approved treatments.

    Nicotine dependence is the single greatest cause of morbidity and mortality in the world. It is important for all physicians and other health care workers to be well trained to be able to effectively engage patients in the discussion of abstinence. It is important that once the patient is engaged in trying to quit the physician or health care worker have an understanding of the evidence based treatments.

    Learning Objectives:

    1. Have and understanding of the impact nicotine dependence has on health.
    2. Understand ways in which a health care worker can approach the patient increasing the chance of behavior change.
    3. Understand the more common forms of treatment. There will be a discussion of "vaping” included n this section.

    R. Gregory Lande, DO, FAOAAM

    R. Gregory Lande, DO is a past president of the AOAAM.

    Dr. Lande retired from active duty military service and now practices psychiatry at Walter Reed National Military
    Medical center in Bethesda, MD.
    He is the author of over 100 articles, chapters, and books.

  • Essentials - Co-occurring and Substance Induced Disorders

    Contains 4 Component(s), Includes Credits

    There is a well-known association of mental health problems and the development and persistence of a substance use problem. This is often referred to as co-morbid illness.

    There is a well-known association of mental health problems and the development and persistence of a substance use problem. This is often referred to as co-morbid illness. This presentation will describe some of the more common associations of the two illnesses from both a developmental and neurobiologic perspectives. There will also be a presentation of the basic understanding of treatment of these patients.

    Learning Objectives:

    1. To have a better understanding of the origin of co-morbid illness.
    2. To understand some of the more common presentations.
    3. To understand the basic principles of treatment of the co-morbid patient.

    R. Gregory Lande, DO, FAOAAM

    R. Gregory Lande, DO is a past president of the AOAAM.

    Dr. Lande retired from active duty military service and now practices psychiatry at Walter Reed National Military
    Medical center in Bethesda, MD.
    He is the author of over 100 articles, chapters, and books.

  • Essentials: General Principles of Drug Testing

    Contains 4 Component(s), Includes Credits

    A look at two broad types of drug testing, office based and work place.

    A look at two broad types of drug testing, office based and work place.

    Learning Objectives:

    To better understand office based and work place drug testing.

    R. Gregory Lande, DO, FAOAAM

    R. Gregory Lande, DO is a past president of the AOAAM.

    Dr. Lande retired from active duty military service and now practices psychiatry at Walter Reed National Military
    Medical center in Bethesda, MD.
    He is the author of over 100 articles, chapters, and books.

  • Telemedicine: Getting Started, Regulations and Privacy Issues

    Contains 3 Component(s) Recorded On: 03/27/2020

    This webinar hosted by American Osteopathic Academy of Addiction Medicine through a Opioid Response Network STR-TA grant will present ways to incorporate telemedicine into treatment programming for substance use disorders, including how to evaluate and expand access to Medications for Addiction Treatment using telemedicine, types of telehealth provider settings, implementation of PCSS best practices and evolving barriers. Recorded - 3/27/2020

    The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 enacted by Congress on March 6, 2020.  As a result, this would allow broader use of and payment for telehealth services for Medicare beneficiaries during the emergency period as defined under the legislation.  Also due to the COVID-19 national public health emergency, as of March 16, 2020, and continuing for as long as the designation of a public health emergency remains, DEA-registered practitioners may issues prescriptions for schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation providing certain other conditions are met.  Furthermore, restrictions on where telemedicine may be practiced have been suspended.  These recent emergency changes in telemedicine regulations open new opportunities in the assessment and treatment of opioid use disorder during these turbulent times.  

    This webinar, hosted by the American Osteopathic Academy of Addiction Medicine through a Opioid Response Network STR-TA grant, will discuss changes in regulations, present ways to incorporate telemedicine into your current practice of treating OUD in the time of social distancing and stay at home orders, and discuss how to get reimbursed for this service. 

    Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    Recorded 3/27/2020

    William Morrone, DO, MS, MPH, DABAM, FACOFP, DAAPM

    Medical Director at Recovery Pathways, principal investigator in a naloxone distribution for Mid-Michigan, Medical Director of 35th Circuit Shiawassee County Drug Court

    Associate Professor of Family and Community Medicine, Michigan State University for 18 years and was Asst. Program Director of Family Medicine at Synergy Medical Education Alliance and liaison in the Department of Psychiatry. He has presented or published in:

    Journal of Addictive Diseases (2015 and 2016), American Journal of Addiction (2013), Substance Abuse (2013), BridgeMI.com 2016-2018 (journalism co-op for setting policy), FoxNews.com (editorial) and CNN.com (news), Weekly medical columns in the Gladwin Record and Courier.

    MLive.com, NPR, Arizona Public Radio, American Public Radio and Michigan Public Radio, Adolescent Addiction from the Conrad Hilton Foundation, CORE REMS as a charter master faculty PCSS monthly training sponsored by SAMHSA/CSAT for 9 yr, MOA/MAOFP news letters; AOA publications & advocacy to recognize addiction medicine

    Dr. Morrone has published a naloxone book for families.  AMERICAN NARCAN (2017)  www.AmericanNarcan.com

    He is triple board certified by the American Board of Addiction Medicine, American College of Osteopathic Family Practitioners and the American Academy of Pain Management. Dr. Morrone was a Ruth Fox faculty for the 42nd ASAM 2011 Medical-Scientific Conference Washington DC and is an active addiction educator and social advocate in pain management.

    Nationally and locally he has contributed numerous didactic pieces on opiates, cannabis dependence, primary care, NAS, state based medical marijuana, non-narcotic pain management to providers in recovery; to the state medical and national societies in this area. He is Deputy Medical Director to the Bay County Health Department and principal investigator on Bay County Heroin Task Force.

    He also holds a graduate degree in toxicology and pharmacology from the University of Missouri at Kansas City, graduate school of pharmacy. He also completed an MPH in Baltimore, MD.

    Most notable to pop culture cable TV news viewers is that he has been on Dr. Drew-HLN, CNN News Room, Nancy Grace-CNN Headline News, Court TV, CNN, Studio “B” FOXNews Channel and MSNBC giving medical opinions on drug addiction or death and the 6 stages of decomposition.  For international overdose awareness day (IOAD) he appeared on 23 TV stations in one day.

    Public service is no stranger to Dr. Morrone as he is a Deputy Chief Medical Examiner, a Diplomat of American College of Forensic Examiners and has been a volunteer firefighter. Dr. Morrone is an aggressive advocate for substance abuse treatment and overdose prevention at the FDA, HHS, SAMHSA and congress.  He also trained at the Armed Forces Institute of Pathology (AFIP) in Maryland.

    Spent 10 years as Medical Director at Hospice of Michigan, leaving hospice to do addiction full time. Dr. Morrone is a graduate of MSU, served his internship in internal medicine in Lansing at Ingham Regional Medical Center and his residency in family medicine at the Michigan State University statewide campus site at Bay Regional Medical Center. http://wwwAmericanNarcan.com.

    Julie Kmiec, DO (Moderator)

    AOAAM President

    Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific.  She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA.  She is currently an Assistant Professor of Psychiatry at the University of Pittsburgh School of Medicine.  She is board certified in general and addiction psychiatry.  Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program, Bridge Clinic, and is the founding medical director of the Narcotic Addiction Treatment Program’s Buprenorphine Clinic at WPIC.  Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions.  Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder.  She is the President of the American Osteopathic Academy of Addiction Medicine.

  • Essentials: Neurobiology of Addictions

    Contains 4 Component(s), Includes Credits

    The goal in presenting this lecture is to give an overview of the current theory of addiction as a brain disease, review the stages of addiction associated with this model and explain the concept of neuroplasticity and how neuroplastic changes in brain chemistry and synapses account for the characteristic behaviors seen in addiction.

    One of the major problems facing our society is drug abuse and addiction, which has reached epidemic proportions in many parts of the country in recent years. In order to better understand this disorder and advocate for treatment for patients, physicians need updated information on the current research in addiction medicine. In my lecture, I review the current model of addiction as a disease of the brain and review the stages of addiction, as they relate to changes in the neurobiology of the brain. This will provide physicians with a better understanding of the relationship between chemical changes in the brain, brain function and addiction and broaden an understanding of addiction as a brain disease.

    Learning Objectives:
    1. give an overview of the current theory of addiction as a brain disease
    2. review the stages of addiction associated with this model
    3. explain the concept of neuroplasticity and how neuroplastic changes in brain chemistry and synapses account for the characteristic behaviors seen in addiction.

    R. Gregory Lande, DO, FAOAAM (Moderator)

    R. Gregory Lande, DO is a past president of the AOAAM.

    Dr. Lande retired from active duty military service and now practices psychiatry at Walter Reed National Military
    Medical center in Bethesda, MD.
    He is the author of over 100 articles, chapters, and books.